INJECTION SITE ERYTHEMA

Adverse reaction reported in 93,193 FDA reports across 18 drugs.

93,193
Total Reports
18
Drugs Involved
Etanercept
Most Reported Drug

Drugs Associated with INJECTION SITE ERYTHEMA

Drugs where "INJECTION SITE ERYTHEMA" was reported as an adverse event.

# Drug Reports % of Total
1 Etanercept 41,025
44.0%
2 Adalimumab 15,205
16.3%
3 Dupilumab 10,065
10.8%
4 Teriparatide 5,052
5.4%
5 Tirzepatide 4,771
5.1%
6 Interferon Beta-1a 3,782
4.1%
7 Glatiramer 2,455
2.6%
8 Ixekizumab 2,178
2.3%
9 Dulaglutide 1,634
1.8%
10 Galcanezumab-Gnlm 1,111
1.2%
11 Peginterferon Beta-1a 1,058
1.1%
12 Interferon Beta-1b 977
1.0%
13 Asfotase Alfa 844
0.9%
14 Pegvaliase-Pqpz 721
0.8%
15 Anakinra 711
0.8%
16 Alirocumab 702
0.8%
17 Fremanezumab-Vfrm 634
0.7%
18 Romosozumab-Aqqg 268
0.3%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused injection site erythema. Always consult your healthcare provider.